Dichloropane
Overview[edit]
Dichloropane is a synthetic stimulant drug of the phenyltropane class. It is a potent dopamine reuptake inhibitor, which means it increases the levels of dopamine in the brain by preventing its reabsorption into neurons. This action is similar to that of cocaine, although dichloropane is structurally distinct.
Chemical Structure[edit]

Dichloropane is chemically known as 2_-carbomethoxy-3_-(3,4-dichlorophenyl)tropane. It belongs to the phenyltropane family, which are analogs of tropane alkaloids. The presence of the dichlorophenyl group is a key feature that distinguishes it from other phenyltropanes.
Pharmacology[edit]
Dichloropane acts primarily as a dopamine reuptake inhibitor, but it also affects the reuptake of serotonin and norepinephrine to a lesser extent. This broad spectrum of activity contributes to its stimulant effects. The inhibition of dopamine reuptake leads to increased concentrations of dopamine in the synaptic cleft, enhancing dopaminergic neurotransmission.
Effects[edit]
The effects of dichloropane are similar to those of other stimulants, including increased alertness, euphoria, and enhanced cognitive performance. However, it also carries risks of adverse effects such as anxiety, paranoia, and potential for addiction due to its impact on the brain's reward system.
Synthesis[edit]
The synthesis of dichloropane involves the modification of the tropane ring system, typically starting from tropinone. The introduction of the dichlorophenyl group is a critical step in the synthesis, which requires careful control of reaction conditions to achieve the desired stereochemistry.
Legal Status[edit]
The legal status of dichloropane varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use.
Related Compounds[edit]
Dichloropane is related to other phenyltropanes such as RTI-55 and RTI-31, which also act as dopamine reuptake inhibitors. These compounds are often studied for their potential use in treating disorders such as ADHD and narcolepsy, although their stimulant properties pose challenges for therapeutic use.
See Also[edit]
Related Pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian